Cannabis Access Expands as Repeal Battle Escalates

Kentucky reached a statewide medical cannabis access milestone while Massachusetts political leaders mobilized against a proposal to dismantle legal adult-use sales. In entertainment, an A24 documentary delivered a notable theatrical breakout alongside the new Street Fighter adaptation.

Rescheduling Stalls as Cronos Expands and Netflix Changes Course

Federal marijuana rescheduling faces another procedural delay while Cronos Group establishes a major position in Europe’s regulated adult-use market. In entertainment, Netflix is installing veteran executive Peter Rice atop its global content operation.

Cannabis Ballot Risk Rises as AI Tensions Hit Hollywood

Massachusetts voters confront a potentially historic cannabis rollback, High Tide expands its Canadian retail footprint, and Nicolas Cage’s dispute with Amazon puts Hollywood’s AI consent battle back in focus.

Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy

Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.

Cannabis Growth Meets Tougher Enforcement as Hollywood Consolidates

New York posted record quarterly cannabis sales, Michigan revoked a retailer’s license over serious compliance violations, and Paramount set an expected closing date for its Warner Bros. Discovery acquisition.

Cannabis Oversight Shifts as Safety and Scale Drive the News

Canada is considering a major reduction in cannabis reporting requirements, while Colorado regulators warn consumers about contaminated vape products sold statewide. In entertainment, Universal became the first studio to cross $5 billion at the 2026 global box office.